NCT00267046 Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma Status COMPLETED Phase PHASE2
NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00262821 Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Status TERMINATED Phase PHASE3
NCT00262769 Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors Status COMPLETED Phase PHASE3
NCT00259285 Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00258323 Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00257816 Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma Status COMPLETED Phase PHASE2
NCT00255476 The IRESSA Novel Head and Neck Chemotherapy Evaluation Study Status COMPLETED Phase PHASE2
NCT00254904 Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC Status TERMINATED Phase PHASE3
NCT00254384 Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery Status COMPLETED Phase PHASE1
NCT00253591 Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00253370 Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00251550 Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE1/PHASE2
NCT00251407 Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00248495 Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00248482 Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00242762 ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer Status COMPLETED Phase PHASE2